查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2096515

即時PCR市場－2026-2032年全球市場預測

Real-time PCR Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，即時PCR市場規模將達到 94.9 億美元，複合年成長率為 7.61%。

主要市場統計數據
基準年 2025 56.7億美元
預計年份：2026年 60.9億美元
預測年份 2032 94.9億美元
複合年成長率 (%) 7.61%

即時PCR執行摘要

即時PCR（也稱為定量PCR或qPCR）因其在密封管內即可實現高靈敏度、高特異性、快速定量分析等優點，仍是應用最廣泛的分子診斷和生命科學研究技術之一。該技術是傳染病檢查、腫瘤研究、基因分析、藥物基因組學、食品安全、藥物基因體學診斷、環境監測和生物製藥品管等領域核酸檢測和定量的基礎。隨著檢查室對更快的樣本到結果處理檢體、病原體多重檢測、抗生素抗藥性監測、伴隨診斷開發和高通量研究應用的需求日益成長，即時螢光定量PCR的重要性也與日俱增。

即時PCR領域的變革性變化

即時PCR）領域正從以儀器​​為中心的檢測方式發展成為一個整合的分子生態系統，將樣本製備、擴增、分析、報告和數據管理等環節連接起來。檢查室擴大採用自動化提取系統、預先檢驗的檢測板、液體處理平台以及與實驗室資訊系統的整合，以減少人為操作誤差並縮短檢測週期。多重qPCR能夠從有限的檢體量中同時檢測多種病原體、遺傳標記或對照標靶，從而拓展了該技術的臨床和科研效用。

人工智慧對即時PCR的累積影響

人工智慧正逐步影響即時PCR工作流程，改善檢測設計、品管、數據解讀和操作效率。人工智慧驅動的引子和探針設計工具可以篩檢標靶區特異性、二級結構、序列變異和潛在的交叉反應，幫助研究人員加速偵測方法的開發，同時減少實驗迭代次數。在臨床和應用檢測領域，機器學習技術正被探索用於提高擴增曲線分類的準確性、標記異常測量結果、檢測抑制模式，並支援不同操作人員和儀器之間設定一致的閾值。

關於即時PCR的關鍵區域見解

亞太地區即時PCR）技術的應用前景廣闊，這主要得益於分子診斷能力的提升、公共衛生投入的增加、生物醫學研究活動的活性化以及對感染疾病、腫瘤和基因檢測需求的成長。儘管中國、印度、日本、韓國、澳洲和東南亞國協的檢查室基礎設施正在不斷發展，qPCR仍被廣泛用作區域疾病監測計畫中快速、精準的檢測工具。北美地區則擁有先進的臨床實驗室網路、完善的法律規範、針對特定分子檢測的保險報銷機制，以及qPCR在醫院診斷、藥物研發、學術實驗室和公共衛生機構的廣泛應用。在美國和加拿大，檢測品質、自動化以及與電子健康數據的整合仍然是關鍵的考量。

即時PCR的關鍵組分析

北約成員國尤其重視生物安全、生物防禦系統、軍事醫學和病原體快速偵測，提升了qPCR在監測、集體爆發應變和作戰衛生防護方面的戰略價值。在七國集團（G7）國家，即時PCR在臨床診斷、藥物研發、腫瘤研究、抗菌素抗藥性監測和公共衛生應對等領域廣泛應用，並得到健全的檢查室認證系統和法律規範的支持。金磚國家由於大規模的人口醫療保健需求、不斷擴展的生物技術研究以及對國內診斷試劑生產和檢查室自主性的日益重視，構成了一個多元化但對即時PCR技術具有重要戰略意義的群體。在中國、印度、巴西、俄羅斯和南非， 即時PCR被廣泛應用於感染疾病控制、農業生物技術、臨床診斷和調查等領域，但各國和地區的基礎設施成熟度有所不同。

各國即時PCR的關鍵訊息

美國憑藉其完善的臨床實驗室基礎設施、公共衛生檢測網路、學術研究活動以及在感染疾病、腫瘤和生物製藥領域的廣泛應用，仍然是即時PCR最先進的國家之一。中國正迅速提升其在公共衛生、醫院診斷、生物技術和生命科學研究領域的qPCR能力，並在感染疾病監測和基因檢測方面廣泛應用。德國則憑藉其強大的診斷體系、雄厚的工程基礎以及分子檢測在臨床和工業領域的廣泛應用而佔據優勢。加拿大注重品管控制的分子診斷、公共衛生監測和研究整合，而日本則以高標準的檢查室、先進的設備以及在腫瘤、感染疾病和藥物研發領域的應用為特色。

為即時PCR行業領導者提供的實用建議

產業領導者應優先考慮工作流程整合，將樣本準備、擴增、分析和報告整合到標準化、可追溯的流程中，從而減少工作量和操作人員差異。檢測方法開發人員應專注於具有臨床意義的多重檢測、可靠的內部對照以及與多種檢體類型的兼容性，以提高診斷效用。檢查室應投資於員工培訓、能力驗證、污染預防和完善的驗證方案，以確保在臨床、研究和應用檢測環境整體對qPCR結果的可靠性。

即時PCR技術調查方法

本執行摘要採用系統的二手資料調查方法編寫，重點關注與即時PCR技術、分子診斷及其在生命科學領域的應用相關的檢驗且有數據支持的資訊來源。該方法包括對同行評審的科學文獻、監管指導文件、公共衛生機構出版刊物、臨床實驗室標準、專利和技術趨勢資訊以及與分子檢測、檢測方法檢驗、感染疾病監測和基因組醫學相關的公開政策資料的審查。

結論：即時PCR作為核心分子技術

即時PCR）仍然是臨床診斷、科學研究、公共衛生和應用生物科學領域中快速、靶向、高靈敏度和定量核酸檢測的核心分子技術。隨著檢查室對更快結果報告、檢驗的多重檢測、自動化工作流程和數位化整合報告系統的需求不斷成長，RT-PCR的角色也不斷擴大。人工智慧的整合、改進的檢測設計以及增強的數據分析能力預計將在不影響嚴格驗證和品管的前提下，進一步提高RT-PCR的可重複性、操作效率和監測能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：即時PCR市場：依產品類型分類

  • 裝置
    • 整合系統
    • 獨立系統
  • 試劑和耗材
    • 酵素
    • 母帶混音
    • 板和管
    • 探針和引子
    • 凝膠密封圈和蓋子
    • RNA/DNA萃取試劑盒
  • 軟體
    • 基於雲端的解決方案
    • 數據分析軟體
  • 服務
    • 安裝和資格確認
    • 校準和預防性維護
    • 培訓和方法開發支持

第8章：即時PCR市場：依技術分類

  • 基於染料的PCR
    • SYBR Green
    • EvaGreen
  • 基於探針的PCR
    • TaqMan
    • 分子信標
    • 蝎子探測器
  • 多重PCR

第9章：即時PCR市場：依工作流程分類

  • 擴增和檢測
  • 數據分析與解讀
  • 樣品製備

第10章：即時PCR市場：依應用領域分類

  • 學術研究
    • 基因組學和轉錄組學
    • 分子生物學研究
    • 藥物發現與開發
  • 臨床診斷
    • 基因檢測
    • 感染疾病
      • 細菌學檢查
      • 寄生蟲檢測
      • 病毒檢測
    • 腫瘤學
      • 基因表現分析
      • 突變檢測
  • 環境測試
  • 食品安全與農業
  • 法醫學

第11章：即時PCR市場：依最終用戶分類

  • 學術研究機構
  • 受託研究機構
  • 診斷檢查室
  • 醫院和診所
  • 製藥和生物技術公司

第12章：即時PCR市場：依地區分類

  • 亞太地區
  • 北美洲
  • 歐洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章：即時PCR市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第14章：即時PCR市場：依國家分類

  • 美國
  • 中國
  • 德國
  • 加拿大
  • 日本
  • 印度
  • 巴西
  • 英國
  • 墨西哥
  • 法國
  • 澳洲
  • 義大利
  • 韓國
  • 俄羅斯
  • 西班牙

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Cepheid by Danaher Corporation
  • Abbott Laboratories
  • QIAGEN NV
  • Promega Corporation
  • Takara Bio Inc.
  • Analytik Jena AG by Endress+Hauser
  • Aperbio Technologies（Suzhou）Co., Ltd.
  • Becton, Dickinson and Company
  • BGI Group
  • DiaSorin SpA
  • Eppendorf AG
  • Everlife-Chemopharm Group
  • GeneDireX, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Mylab Discovery Solutions Pvt. Ltd.
  • PerkinElmer, Inc.
  • Sansure Biotech Inc.
  • SD Biosensor, Inc.
  • Seegene Inc.
  • Siemens Healthineers AG
  • Standard BioTools Inc.
  • Zymo Research Corporation
Product Code: MRR-0D217D5AEDAD

The Real-time PCR Market is projected to grow by USD 9.49 billion at a CAGR of 7.61% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.67 billion
Estimated Year [2026] USD 6.09 billion
Forecast Year [2032] USD 9.49 billion
CAGR (%) 7.61%

Real-time PCR Executive Summary

Real-time PCR, also known as quantitative PCR or qPCR, remains one of the most widely used molecular diagnostics and life sciences research technologies because it combines high analytical sensitivity, specificity, speed, and quantitative readout in a closed-tube workflow. The technology supports detection and quantification of nucleic acids across infectious disease testing, oncology research, genetic analysis, pharmacogenomics, food safety, veterinary diagnostics, environmental monitoring, and biopharmaceutical quality control. Its relevance has strengthened as laboratories prioritize faster sample-to-answer workflows, multiplex pathogen detection, antimicrobial resistance surveillance, companion diagnostic development, and high-throughput research applications.

Adoption is being shaped by continued improvements in assay chemistry, thermal cycling precision, fluorescence detection, automation, and digital connectivity. Demand is also reinforced by public health preparedness, decentralized testing strategies, and the need for reproducible molecular evidence in clinical and regulatory settings. As healthcare systems shift toward precision medicine and earlier disease detection, real-time PCR is positioned as a foundational platform that bridges routine diagnostics, translational research, and applied biosciences.

Transformative Shifts in the Real-time PCR Landscape

The real-time PCR landscape is evolving from instrument-centered testing toward integrated molecular ecosystems that connect sample preparation, amplification, analysis, reporting, and data management. Laboratories are increasingly adopting automated extraction systems, pre-validated assay panels, liquid handling platforms, and laboratory information system connectivity to reduce manual variability and improve turnaround time. Multiplex qPCR is expanding the clinical and research utility of the technology by enabling simultaneous detection of multiple pathogens, genetic markers, or control targets from limited sample volumes.

Another major shift is the movement of molecular testing beyond centralized reference laboratories. Compact qPCR instruments, cartridge-based workflows, and simplified user interfaces are supporting adoption in hospital laboratories, public health networks, field testing settings, and resource-constrained environments. Regulatory emphasis on assay validation, quality controls, and traceability is increasing, particularly for infectious disease diagnostics, oncology applications, and pharmacogenomic testing. At the same time, laboratories are balancing real-time PCR with complementary technologies such as next-generation sequencing and digital PCR, using qPCR for rapid, cost-efficient, targeted detection and confirmation where speed and operational scalability are critical.

Cumulative Impact of Artificial Intelligence on Real-time PCR

Artificial intelligence is progressively influencing real-time PCR workflows by improving assay design, quality control, data interpretation, and operational efficiency. AI-enabled primer and probe design tools can screen target regions for specificity, secondary structures, sequence variability, and potential cross-reactivity, helping researchers accelerate assay development while reducing experimental iteration. In clinical and applied testing environments, machine learning approaches are being explored to improve amplification curve classification, flag anomalous runs, detect inhibition patterns, and support consistent threshold setting across operators and instruments.

AI also enhances laboratory productivity by enabling predictive maintenance, reagent inventory planning, workflow scheduling, and automated review of large qPCR datasets. For infectious disease surveillance, AI-supported analytics can integrate real-time PCR results with epidemiological, geospatial, and temporal data to identify outbreak patterns and guide public health response. In oncology and precision medicine, advanced analytics can support interpretation of gene expression, mutation, and minimal residual disease testing when combined with validated molecular workflows. However, adoption depends on transparent algorithms, robust validation datasets, cybersecurity controls, and compliance with clinical laboratory standards to ensure AI-assisted real-time PCR remains reproducible, auditable, and clinically reliable.

Key Regional Insights for Real-time PCR

Asia-Pacific is a dynamic environment for real-time PCR adoption due to expanding molecular diagnostics capacity, public health investments, biomedical research activity, and rising demand for infectious disease, oncology, and genetic testing. China, India, Japan, South Korea, Australia, and ASEAN economies are strengthening laboratory infrastructure, while regional disease surveillance programs continue to rely on qPCR for rapid and targeted detection. North America is characterized by advanced clinical laboratory networks, strong regulatory oversight, established reimbursement pathways for selected molecular tests, and broad use of qPCR in hospital diagnostics, pharmaceutical research, academic laboratories, and public health agencies. The United States and Canada continue to emphasize assay quality, automation, and integration with electronic health data.

Europe benefits from a mature diagnostics ecosystem, cross-border disease surveillance coordination, and strong adoption of qPCR in oncology, genetic testing, antimicrobial resistance monitoring, and environmental applications. The European Union's emphasis on diagnostic performance evaluation and regulatory compliance is shaping assay validation practices across the region. Latin America is seeing increasing use of real-time PCR in public health laboratories, infectious disease surveillance, food safety testing, and academic research, with Brazil and Mexico serving as important centers for molecular testing capacity. In the Middle East, investments in hospital modernization, genomic medicine initiatives, and national laboratory networks are supporting broader molecular testing deployment, particularly in GCC countries. Africa is expanding real-time PCR capacity through infectious disease programs, reference laboratory development, and international health initiatives, with qPCR playing a central role in surveillance of viral, bacterial, and parasitic diseases despite ongoing challenges in cold-chain logistics, workforce training, and reagent availability.

Key Group Insights for Real-time PCR

NATO member states place particular emphasis on biosecurity, biodefense readiness, military medicine, and rapid pathogen detection, reinforcing the strategic value of qPCR for surveillance, outbreak response, and operational health protection. G7 countries demonstrate advanced use of real-time PCR in clinical diagnostics, pharmaceutical development, oncology research, antimicrobial resistance monitoring, and public health response, supported by strong laboratory accreditation and regulatory frameworks. BRICS economies represent a diverse but strategically important group for real-time PCR due to large population health needs, expanding biotechnology research, and increased focus on domestic diagnostics manufacturing and laboratory self-sufficiency. China, India, Brazil, Russia, and South Africa use qPCR across infectious disease control, agricultural biotechnology, clinical diagnostics, and research applications, although infrastructure maturity varies by country and region.

The European Union is shaping the real-time PCR environment through harmonized regulatory expectations, quality management standards, and coordinated public health surveillance, supporting high confidence in test performance and cross-border comparability. ASEAN countries are strengthening real-time PCR capabilities through public health modernization, hospital laboratory expansion, and infectious disease preparedness, with qPCR widely used for respiratory infections, dengue, tuberculosis, food safety, and veterinary testing. GCC countries are advancing molecular diagnostics through investments in specialized hospitals, precision medicine programs, and centralized laboratory systems, creating favorable conditions for adoption of automated qPCR workflows and validated assay panels.

Key Country Insights for Real-time PCR

The United States remains one of the most advanced environments for real-time PCR, supported by extensive clinical laboratory infrastructure, public health testing networks, academic research activity, and broad use in infectious disease, oncology, and biopharmaceutical applications. China has rapidly expanded qPCR capacity across public health, hospital diagnostics, biotechnology, and life sciences research, with broad application in infectious disease surveillance and genetic testing. Germany benefits from a robust diagnostics culture, strong engineering base, and wide use of molecular assays in clinical and industrial settings. Canada emphasizes quality-controlled molecular diagnostics, public health surveillance, and research integration, while Japan is characterized by high-quality laboratory standards, advanced instrumentation use, and applications in oncology, infectious disease, and pharmaceutical research.

India is increasing real-time PCR adoption through public health laboratories, private diagnostic networks, tuberculosis programs, and growing biomedical research activity. Brazil has strong relevance in Latin America due to its biomedical research base, public health programs, and use of real-time PCR for arboviral diseases, respiratory pathogens, and agricultural testing. The United Kingdom applies qPCR across national health laboratories, genomics research, antimicrobial resistance monitoring, and oncology pathways, while Mexico is expanding qPCR use in infectious disease testing, food safety, and clinical laboratory modernization. France integrates real-time PCR into hospital diagnostics, infectious disease surveillance, and translational research.

Australia uses qPCR extensively in public health, biosecurity, environmental monitoring, veterinary diagnostics, and clinical testing. Italy and Spain continue to rely on qPCR for hospital-based diagnostics, respiratory pathogen detection, oncology research, and food safety monitoring, supported by established laboratory networks. South Korea combines advanced healthcare infrastructure, biotechnology innovation, and strong infectious disease preparedness, supporting sophisticated use of real-time PCR across diagnostics and research. Russia uses qPCR across public health, veterinary diagnostics, and biotechnology research, reinforcing its role in targeted molecular detection and applied bioscience programs.

Actionable Recommendations for Real-time PCR Industry Leaders

Industry leaders should prioritize workflow integration by aligning sample preparation, amplification, analysis, and reporting into standardized, traceable processes that reduce hands-on time and operator variability. Assay developers should focus on clinically relevant multiplex panels, robust internal controls, and compatibility with diverse specimen types to improve diagnostic utility. Laboratories should invest in staff training, proficiency testing, contamination prevention, and documented validation protocols to maintain confidence in qPCR results across clinical, research, and applied testing environments.

Decision-makers should strengthen supply chain resilience for enzymes, primers, probes, plastics, extraction reagents, and calibration materials, as real-time PCR performance depends on consistent reagent quality. Digital connectivity should be treated as a strategic priority, with secure data transfer, interoperable laboratory information systems, and audit-ready analytics supporting regulatory compliance. Organizations adopting AI-enabled qPCR tools should implement validation frameworks that assess accuracy, bias, reproducibility, and explainability before routine deployment. Partnerships with hospitals, public health agencies, academic laboratories, and biomanufacturing facilities can also accelerate application-specific innovation while ensuring that real-time PCR solutions address practical workflow constraints.

Research Methodology for Real-time PCR Insights

This executive summary is developed using a structured secondary research methodology focused on verified, data-backed sources relevant to real-time PCR technology, molecular diagnostics, and life sciences applications. The approach includes review of peer-reviewed scientific literature, regulatory guidance documents, public health agency publications, clinical laboratory standards, patent and technology trend information, and publicly available policy materials related to molecular testing, assay validation, infectious disease surveillance, and genomic medicine.

Insights are synthesized through qualitative triangulation across technology trends, clinical applications, regional laboratory infrastructure, regulatory considerations, and adoption drivers. The methodology excludes market estimation, market sizing, market share, and forecasting analysis. Emphasis is placed on evidence-supported developments such as automation, multiplexing, decentralized molecular testing, AI-assisted analytics, quality management, and regional public health capacity. Country and regional insights are interpreted through observed healthcare infrastructure, research activity, laboratory modernization, and molecular diagnostics implementation patterns.

Conclusion: Real-time PCR as a Core Molecular Technology

Real-time PCR continues to be a core molecular technology because it delivers rapid, targeted, sensitive, and quantitative nucleic acid detection across clinical diagnostics, research, public health, and applied biosciences. Its role is expanding as laboratories demand faster turnaround, validated multiplex assays, automated workflows, and digitally connected reporting systems. The integration of artificial intelligence, improved assay design, and enhanced data analytics is expected to further strengthen reproducibility, operational efficiency, and surveillance capabilities without replacing the need for rigorous validation and quality control.

Across regions and country groups, adoption is shaped by public health priorities, laboratory infrastructure, regulatory maturity, workforce capability, and investment in precision medicine. Industry leaders that focus on workflow reliability, assay quality, automation, digital interoperability, and resilient supply chains will be best positioned to support the next phase of real-time PCR utilization. As healthcare and bioscience sectors continue to prioritize actionable molecular information, qPCR will remain a critical platform for evidence-based decision-making, disease detection, and translational innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Real-time PCR Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments
    • 7.2.1. Integrated Systems
    • 7.2.2. Standalone Systems
  • 7.3. Reagents & Consumables
    • 7.3.1. Enzymes
    • 7.3.2. Master Mix
    • 7.3.3. Plates & Tubes
    • 7.3.4. Probes & Primers
    • 7.3.5. Optical Seals & Caps
    • 7.3.6. RNA/DNA Extraction Kits
  • 7.4. Software
    • 7.4.1. Cloud-Based Solutions
    • 7.4.2. Data Analysis Software
  • 7.5. Services
    • 7.5.1. Installation & Qualification
    • 7.5.2. Calibration & Preventive Maintenance
    • 7.5.3. Training & Method Development Support

8. Real-time PCR Market, by Technology

  • 8.1. Introduction
  • 8.2. Dye-Based PCR
    • 8.2.1. SYBR Green
    • 8.2.2. EvaGreen
  • 8.3. Probe-Based PCR
    • 8.3.1. TaqMan
    • 8.3.2. Molecular Beacons
    • 8.3.3. Scorpion Probe
  • 8.4. Multiplex PCR

9. Real-time PCR Market, by Workflow

  • 9.1. Introduction
  • 9.2. Amplification & Detection
  • 9.3. Data Analysis & Interpretation
  • 9.4. Sample Preparation

10. Real-time PCR Market, by Application

  • 10.1. Introduction
  • 10.2. Academic Research
    • 10.2.1. Genomics & Transcriptomics
    • 10.2.2. Molecular Biology Studies
    • 10.2.3. Drug Discovery & Development
  • 10.3. Clinical Diagnostics
    • 10.3.1. Genetic Testing
    • 10.3.2. Infectious Disease
      • 10.3.2.1. Bacterial Testing
      • 10.3.2.2. Parasitic Testing
      • 10.3.2.3. Viral Testing
    • 10.3.3. Oncology
      • 10.3.3.1. Gene Expression Profiling
      • 10.3.3.2. Mutation Detection
  • 10.4. Environmental Testing
  • 10.5. Food Safety & Agriculture
  • 10.6. Forensics

11. Real-time PCR Market, by End User

  • 11.1. Introduction
  • 11.2. Academic & Research Institutes
  • 11.3. Contract Research Organizations
  • 11.4. Diagnostic Laboratories
  • 11.5. Hospitals & Clinics
  • 11.6. Pharmaceutical & Biotechnology Companies

12. Real-time PCR Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Europe
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. Real-time PCR Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. BRICS
  • 13.4. European Union
  • 13.5. ASEAN
  • 13.6. GCC

14. Real-time PCR Market, by Country

  • 14.1. United States
  • 14.2. China
  • 14.3. Germany
  • 14.4. Canada
  • 14.5. Japan
  • 14.6. India
  • 14.7. Brazil
  • 14.8. United Kingdom
  • 14.9. Mexico
  • 14.10. France
  • 14.11. Australia
  • 14.12. Italy
  • 14.13. South Korea
  • 14.14. Russia
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Thermo Fisher Scientific, Inc.
  • 16.2. F. Hoffmann-La Roche AG
  • 16.3. Bio-Rad Laboratories, Inc.
  • 16.4. Merck KGaA
  • 16.5. Agilent Technologies, Inc.
  • 16.6. Cepheid by Danaher Corporation
  • 16.7. Abbott Laboratories
  • 16.8. QIAGEN N.V.
  • 16.9. Promega Corporation
  • 16.10. Takara Bio Inc.
  • 16.11. Analytik Jena AG by Endress+Hauser
  • 16.12. Aperbio Technologies(Suzhou) Co., Ltd.
  • 16.13. Becton, Dickinson and Company
  • 16.14. BGI Group
  • 16.15. DiaSorin S.p.A.
  • 16.16. Eppendorf AG
  • 16.17. Everlife-Chemopharm Group
  • 16.18. GeneDireX, Inc.
  • 16.19. Hologic, Inc.
  • 16.20. Illumina, Inc.
  • 16.21. Mylab Discovery Solutions Pvt. Ltd.
  • 16.22. PerkinElmer, Inc.
  • 16.23. Sansure Biotech Inc.
  • 16.24. SD Biosensor, Inc.
  • 16.25. Seegene Inc.
  • 16.26. Siemens Healthineers AG
  • 16.27. Standard BioTools Inc.
  • 16.28. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL REAL-TIME PCR MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL REAL-TIME PCR MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL REAL-TIME PCR MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL REAL-TIME PCR MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL REAL-TIME PCR MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL REAL-TIME PCR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTEGRATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTEGRATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTEGRATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STANDALONE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STANDALONE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STANDALONE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MASTER MIX MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MASTER MIX MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MASTER MIX MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PLATES & TUBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLATES & TUBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PLATES & TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PROBES & PRIMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PROBES & PRIMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PROBES & PRIMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OPTICAL SEALS & CAPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OPTICAL SEALS & CAPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OPTICAL SEALS & CAPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RNA/DNA EXTRACTION KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RNA/DNA EXTRACTION KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RNA/DNA EXTRACTION KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CLOUD-BASED SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CLOUD-BASED SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CLOUD-BASED SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INSTALLATION & QUALIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INSTALLATION & QUALIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INSTALLATION & QUALIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CALIBRATION & PREVENTIVE MAINTENANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CALIBRATION & PREVENTIVE MAINTENANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CALIBRATION & PREVENTIVE MAINTENANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TRAINING & METHOD DEVELOPMENT SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRAINING & METHOD DEVELOPMENT SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TRAINING & METHOD DEVELOPMENT SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DYE-BASED PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DYE-BASED PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DYE-BASED PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SYBR GREEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SYBR GREEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SYBR GREEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL EVAGREEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL EVAGREEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL EVAGREEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PROBE-BASED PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PROBE-BASED PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PROBE-BASED PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TAQMAN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TAQMAN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TAQMAN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MOLECULAR BEACONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MOLECULAR BEACONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MOLECULAR BEACONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SCORPION PROBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SCORPION PROBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SCORPION PROBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MULTIPLEX PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MULTIPLEX PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MULTIPLEX PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AMPLIFICATION & DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AMPLIFICATION & DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AMPLIFICATION & DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DATA ANALYSIS & INTERPRETATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DATA ANALYSIS & INTERPRETATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DATA ANALYSIS & INTERPRETATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ACADEMIC RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MOLECULAR BIOLOGY STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MOLECULAR BIOLOGY STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MOLECULAR BIOLOGY STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BACTERIAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BACTERIAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BACTERIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PARASITIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PARASITIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PARASITIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL VIRAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VIRAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL VIRAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL GENE EXPRESSION PROFILING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL GENE EXPRESSION PROFILING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL GENE EXPRESSION PROFILING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MUTATION DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MUTATION DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MUTATION DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL FOOD SAFETY & AGRICULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL FOOD SAFETY & AGRICULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL FOOD SAFETY & AGRICULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL FORENSICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL FORENSICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL FORENSICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. NATO REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 254. NATO REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 257. NATO REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 259. NATO REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. NATO REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 261. NATO REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 262. NATO REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 263. NATO REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. NATO REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 265. NATO REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 266. NATO REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 267. NATO REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. NATO REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. G7 REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 270. G7 REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. G7 REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 272. G7 REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 273. G7 REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 274. G7 REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 275. G7 REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. G7 REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 277. G7 REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 278. G7 REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 279. G7 REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. G7 REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 281. G7 REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 282. G7 REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 283. G7 REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 284. G7 REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. ASEAN REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 318. ASEAN REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. ASEAN REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 320. ASEAN REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 321. ASEAN REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 322. ASEAN REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 323. ASEAN REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 324. ASEAN REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 325. ASEAN REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 326. ASEAN REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 327. ASEAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 328. ASEAN REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 329. ASEAN REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 330. ASEAN REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 331. ASEAN REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 332. ASEAN REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. GCC REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 334. GCC REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. GCC REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 336. GCC REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 337. GCC REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 338. GCC REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 339. GCC REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 340. GCC REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 341. GCC REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 342. GCC REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 343. GCC REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 344. GCC REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 345. GCC REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 346. GCC REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 347. GCC REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 348. GCC REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 349. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED STATES REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED STATES REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 359. UNITED STATES REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 360. UNITED STATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 361. UNITED STATES REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 362. UNITED STATES REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 363. UNITED STATES REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 364. UNITED STATES REAL-TIME PCR MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 365. UNITED STATES REAL-TIME PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 366. CHINA REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 367. CHINA REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 368. CHINA REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 369. CHINA REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 370. CHINA REAL-TIME PCR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 371. CHINA REAL-TIME PCR MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 372. CHINA REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 373. CHINA REAL-TIME PCR MARKET SIZE, BY DYE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 374. CHINA REAL-TIME PCR MARKET SIZE, BY PROBE-BASED PCR, 2018-2032 (USD MILLION)
  • TABLE 375. CHINA REAL-TIME PCR MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 376. CHINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 377. CHINA REAL-TIME PCR MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 378. CHINA REAL-TIME PCR MARKET SIZE, BY CLINICA